Presidio Medical

Presidio Medical is a privately held, clinical-stage medical device company headquartered in South San Francisco, California, founded in 2017 by Kenneth Wu and led by CEO and Chairman Michael Onuscheck. It is developing an implantable Ultra Low Frequency (ULF) neuromodulation platform intended to treat diseases of undesired neural activity, with a first indication in chronic nociceptive low back pain. The therapy delivers ultra low frequency current through an epidural spinal cord stimulation (SCS) lead to reversibly inhibit pain-signaling neurons via sodium channel inactivation, positioned as a non-opioid alternative to conventional SCS. The company raised a $72M Series C in 2023 led by Deerfield Management with Invus Opportunities, Action Potential Venture Capital and ShangBay Capital, and received FDA IDE approval for the global pivotal FULFILL randomized controlled trial in the United States and Australia. Presidio Medical sells an implantable medical device, not software; it has never operated a developer program, public API, SDK or machine-readable API contract. As of 2026-08-05 its corporate WordPress site at presidiomedical.com is offline, returning a WP Engine "Site Not Configured" HTTP 404 on every path including the root.

Presidio Medical is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Neuromodulation, Neurotechnology, and Spinal Cord Stimulation.

🌐 Visit website 📡 Source on GitHub
3.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-19 · rubric v0.12.0
0 APIs
CompanyMedical DevicesNeuromodulationNeurotechnologySpinal Cord StimulationChronic PainImplantable DevicesClinical StageHealthcareLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-19 · rubric v0.12.0
Composite quality — 3.7/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.6 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/presidio-medical: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Presidio Medical Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 3

The organization behind the API

Website
Website
 LinkedIn
LinkedIn
 Investors
Investors

Source (apis.yml)

apis.yml Raw ↑ 
aid: presidio-medical
name: Presidio Medical
description: Presidio Medical is a privately held, clinical-stage medical device company headquartered in South San Francisco,
  California, founded in 2017 by Kenneth Wu and led by CEO and Chairman Michael Onuscheck. It is developing an implantable
  Ultra Low Frequency (ULF) neuromodulation platform intended to treat diseases of undesired neural activity, with a first
  indication in chronic nociceptive low back pain. The therapy delivers ultra low frequency current through an epidural spinal
  cord stimulation (SCS) lead to reversibly inhibit pain-signaling neurons via sodium channel inactivation, positioned as
  a non-opioid alternative to conventional SCS. The company raised a $72M Series C in 2023 led by Deerfield Management with
  Invus Opportunities, Action Potential Venture Capital and ShangBay Capital, and received FDA IDE approval for the global
  pivotal FULFILL randomized controlled trial in the United States and Australia. Presidio Medical sells an implantable medical
  device, not software; it has never operated a developer program, public API, SDK or machine-readable API contract. As of
  2026-08-05 its corporate WordPress site at presidiomedical.com is offline, returning a WP Engine "Site Not Configured" HTTP
  404 on every path including the root.
url: https://raw.githubusercontent.com/api-evangelist/presidio-medical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Medical Devices
- Neuromodulation
- Neurotechnology
- Spinal Cord Stimulation
- Chronic Pain
- Implantable Devices
- Clinical Stage
- Healthcare
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/presidio-medical-domain-security.yml
- type: LLMsTxt
  url: llms/presidio-medical-llms.txt
- type: Website
  url: https://presidiomedical.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/presidio-medical-inc
- type: Investors
  url: https://forgeglobal.com/presidio-medical_stock/
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Presidio Medical manufactures an implantable ultra-low-frequency spinal cord stimulator and has never run a developer
    program; on top of that its corporate WordPress site went offline sometime after the Internet Archive's last 200 capture
    on 2026-06-07 and now returns a WP Engine "Site Not Configured" HTTP 404 on every path including the root and a control
    path, while no api/developer/docs/portal subdomain resolves at all.
  evidence:
  - url: https://presidiomedical.com/
    status: 404
  - url: https://presidiomedical.com/openapi.json
    status: 404
  - url: https://presidiomedical.com/.well-known/agent-card.json
    status: 404
  - url: https://presidiomedical.com/llms.txt
    status: 404
  checked: '2026-08-05'